Other

Deferred Tax Assets Capitalized Research And Development

Corvex Deferred Tax Assets Capitalized Research And Development decreased by 27.5% to $5.16M in Q4 2025 compared to the prior quarter. Over 2 years (FY 2023 to FY 2025), Deferred Tax Assets Capitalized Research And Development shows a downward trend with a -7.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryEfficiency
SignalHigher is better
VolatilityStable
First reportedQ4 2023
Last reportedQ4 2025

How to read this metric

An increase indicates higher tax-deductible R&D spending that will lower future tax payments.

Detailed definition

This represents the tax benefit arising from the capitalization of research and development expenses for tax purposes, w...

Peer comparison

Standard for technology companies subject to tax laws requiring R&D capitalization; peers report this in deferred tax disclosures.

Metric ID: other_deferred_tax_assets_capitalized_research_and_devel_3897a0

Historical Data

3 periods
 Q4 '23Q4 '24Q4 '25
Value$5.96M$7.12M$5.16M
QoQ Change+19.3%-27.5%
YoY Change+19.3%-27.5%
Range$5.16M$7.12M
Avg YoY Growth-4.1%
Median YoY Growth-4.1%

Frequently Asked Questions

What is Corvex 's deferred tax assets capitalized research and development?
Corvex (MOVE) reported deferred tax assets capitalized research and development of $5.16M in Q4 2025.
What is the long-term trend for Corvex 's deferred tax assets capitalized research and development?
Over 2 years (2023 to 2025), Corvex 's deferred tax assets capitalized research and development has grown at a -7.0% compound annual growth rate (CAGR), from $5.96M to $5.16M.
What does deferred tax assets capitalized research and development mean?
Tax benefits resulting from the difference between how R&D costs are treated for tax versus accounting purposes.